All Stories

  1. Respiratorische Erkrankungen
  2. Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment
  3. Acute Hemodynamic Effects of Sotatercept
  4. Dual Impacts of Lung Transplantation on the Recovery and Comorbidity of Interstitial Lung Diseases: A Longitudinal Assessment of the Benefits and Burden
  5. Increase in Alveolar Septal Width Is a Histological Predictor of Chronic Lung Allograft Dysfunction and Survival in Lung Transplant Recipients—A Longitudinal Study
  6. Method for generating right ventricular pressure-volume loops in routine practice
  7. Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry Analysis
  8. Echocardiographic Measure of Right Ventricular–Pulmonary Arterial Coupling Predicts Survival in Lung Cancer
  9. Right-sided heart failure in acute respiratory distress syndrome
  10. Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta‐Registry
  11. Automated CT Image Processing for the Diagnosis, Prediction, and Differentiation of Phenotypes in Chronic Lung Allograft Dysfunction After Lung Transplantation
  12. Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry
  13. Exercise Limitation in Pulmonary Hypertension – Physiological Insights into the 6-Minute Walk Test
  14. The Diagnostic Accuracy of an Electrocardiogram in Pulmonary Hypertension and the Role of “R V1, V2 + S I, aVL − S V1”
  15. Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension
  16. Air travel in patients suffering from pulmonary hypertension—A prospective, multicentre study
  17. Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension
  18. A Novel Rat Model of Mild Pulmonary Hypertension Associated with Pulmonary Venous Congestion Induced by Left Pulmonary Vein Banding
  19. Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension
  20. Changes in Doppler‐Derived Kidney Venous Flow and Adverse Cardiorenal Outcomes in Patients With Heart Failure
  21. Echocardiographic evaluation of right ventricular diastolic function in pulmonary hypertension
  22. Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters
  23. The C0-C1f Region of Cardiac Myosin Binding Protein-C Induces Pro-Inflammatory Responses in Fibroblasts via TLR4 Signaling
  24. Right ventricular pressure-volume loop shape and systolic pressure change in pulmonary hypertension
  25. Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
  26. Pulmonary complications of tyrosine kinase inhibitors in myeloproliferative disorders
  27. Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
  28. Risk assessment in severe pulmonary hypertension due to interstitial lung disease
  29. Sex Differences in Right Ventricular–Pulmonary Arterial Coupling in Pulmonary Arterial Hypertension
  30. Impact of timing on right heart catheterization measurements in pulmonary hypertension
  31. Gamma-Glutamyltransferase in pulmonary hypertension: A reliable biomarker?
  32. Reliability of echo systolic pulmonary arterial pressure to detect new definition of pulmonary hypertension
  33. Risk assessment in severe pulmonary hypertension due to interstitial lung disease
  34. In-depth risk stratification in pulmonary arterial hypertension
  35. Impact of SARS-CoV-2 pandemic on pulmonary hypertension out-patient clinics in Germany: a multi-centre study
  36. Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter?
  37. P4764Development of a qualitative and quantitative detection method for the N-terminal fragment of cardiac myosin-binding protein C